MedEquities Realty Trust (MRT) Rating Lowered to D+ at TheStreet

MedEquities Realty Trust (NYSE:MRT) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research note issued to investors on Friday.

A number of other brokerages have also issued reports on MRT. KeyCorp lowered shares of MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 target price on the stock. in a research report on Wednesday, August 8th. Zacks Investment Research lowered shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research report on Saturday, August 11th. Citigroup upgraded shares of MedEquities Realty Trust from a “sell” rating to a “neutral” rating and set a $9.00 target price on the stock in a research report on Monday, November 12th. JMP Securities set a $12.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research report on Tuesday, October 23rd. Finally, ValuEngine lowered shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 8th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. MedEquities Realty Trust currently has an average rating of “Hold” and an average target price of $11.00.

Shares of MedEquities Realty Trust stock opened at $6.92 on Friday. MedEquities Realty Trust has a 1-year low of $6.75 and a 1-year high of $12.00. The stock has a market cap of $217.94 million, a price-to-earnings ratio of 6.07 and a beta of 0.58.

MedEquities Realty Trust (NYSE:MRT) last announced its earnings results on Monday, November 12th. The financial services provider reported ($0.07) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.18 by ($0.25). MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. The company had revenue of $9.68 million for the quarter, compared to analyst estimates of $17.72 million. On average, sell-side analysts predict that MedEquities Realty Trust will post 0.8 EPS for the current fiscal year.

In related news, Director Bluemountain Capital Managemen sold 29,051 shares of the stock in a transaction that occurred on Friday, November 30th. The shares were sold at an average price of $6.99, for a total value of $203,066.49. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders have sold 441,328 shares of company stock worth $3,613,650 over the last quarter. 3.00% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in MRT. Los Angeles Capital Management & Equity Research Inc. acquired a new position in MedEquities Realty Trust in the second quarter valued at approximately $131,000. People s United Financial Inc. acquired a new position in MedEquities Realty Trust in the second quarter valued at approximately $158,000. Bank of Montreal Can acquired a new position in MedEquities Realty Trust in the second quarter valued at approximately $160,000. Raymond James Trust N.A. acquired a new position in MedEquities Realty Trust in the third quarter valued at approximately $161,000. Finally, California Public Employees Retirement System acquired a new position in MedEquities Realty Trust in the second quarter valued at approximately $171,000. Institutional investors and hedge funds own 92.13% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: How is inflation measured?

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit